Sapio Sciences provides a lab informatics platform that integrates LIMS, ELN, and SDMS solutions for scientific research, discovery, manufacturing, and clinical diagnostics.

Sapio Sciences

DVLP is building a new infrastructure for drug development by digitizing drug assets, financing, and development workflows to accelerate the process of turning molecules into medicines.

DVLP

Machine Translation utilizes computational biology, novel Machine Learning & AI, bioinformatic simulations, and a unique data set to determine which drug candidates will most likely succeed in clinical studies.

Metric
Company Name	Sapio Sciences	DVLP	Machine Translation
Symbol
MSH ID	COM:SAPIOSCIENCES	COM:DVLPMEDICINES	COM:MACHTRANSPRO
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Technology	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare & Health Services	Pharmaceuticals	Biotechnology
Country	US	US	US
Stage
Employee Count
Website	sapiosciences.com	dvlpmedicines.com	machtranspro.com
LinkedIn		dvlpmedicines
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	133	162.88K
Web Traffic Growth	-0.55	-0.34
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

SAPI

COM:SAPIOSCIENCES

Sapio Sciences

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue